Skip to main content

Currently Skimming:

Appendix B: Speaker Biographical Sketches
Pages 77-84

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 77...
... Ms. Bonadies practiced as a clinical genetic counselor at the Yale School of Medicine for a decade, where she was the assistant director of the Cancer Genetic Counseling Program.
From page 78...
... Board-certified in both obstetrics/­ ynecology ­ g and clinical genetics, she maintains her clinical practice in the Division of Reproductive and Medical Genetics at Montefiore where she works to improve the health of mothers and children by preventing birth defects, preterm birth, and infant mortality. Matthew Ferber, Ph.D., is an assistant professor and a consultant in the Department of Laboratory Medicine and Pathology at the Mayo Clinic, where he serves as a co-director for the Genomics Laboratory.
From page 79...
... regulatory advice for leading medical device, diagnostics, pharmaceutical, biological products, human cellular, and tissue-based products (HCT/Ps) and dietary supplement companies throughout the product life cycle, and she has successfully resolved disputes at both the pre- and postmarket stage.
From page 80...
... Her research is funded by the National Human Genome Research Institute, the National Cancer Institute, and the National Institute of Child Health and Human Development at the National Institutes of Health, and she is a member of the advisory committee for the Greenwall Faculty Scholars Program in Bioethics. Robert Nussbaum, M.D., is the chief medical officer of Invitae, a genetic information and diagnostic company.
From page 81...
... Dr. Nussbaum was awarded the Klaus Joachim Zülch-Prize for Neurological Research, the Jay Van Andel Award for Outstanding Achievement in Parkinson's Disease Research, and the Calne Lectureship from Parkinson Canada for his work on hereditary Parkinson disease.
From page 82...
... During his career he has played important roles in the development and launch of more than 30 in vitro diagnostic products, as well as numerous unique laboratory-­ developed test services, including the FDA-approved companion diagnostic for Novartis's drug Rydapt and the world's first clinical microRNA assay (for pancreatic cancer detection)
From page 83...
... C Biochemical and Molecular Genetics Resource Committee from 1996 to 2005, the Association for Molecular Pathology (AMP) finance committee from 2012 to 2018, the AMP strategic planning committee from 2007 to 2009, as the AMP chair-elect and chair of the Solid Tumor Division from 2003 to 2004, the CAP molecular oncology committee from 2013 to 2018, and as a member of the CAP house of delegates from 2011 to 2017.


This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More information on Chapter Skim is available.